Efficacy and safety of patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC).

被引：31
|
作者：
Janne, Pasi A.
Baik, Christina S.
Su, Wu-Chou
Johnson, Melissa Lynne
Hayashi, Hidetoshi
Nishio, Makoto
Kim, Dong-Wan
Koczywas, Marianna
Gold, Kathryn A.
Steuer, Conor Ernst
Murakami, Haruyasu
Yang, James Chih-Hsin
Kim, Sang-We
Vigliotti, Michele
Qi, Zhenhao
Qiu, Yang
Zhao, Lihui
Sternberg, David W.
Yu, Channing
Yu, Helena Alexandra
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Seattle Canc Care Alliance, Seattle, WA USA
[3] Natl Cheng Kung Univ Hosp, Tainan, Taiwan
[4] Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN USA
[5] Kindai Univ Hosp, Osaka, Japan
[6] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan
[7] Seoul Natl Univ Hosp, Seoul, South Korea
[8] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[9] Univ Calif San Diego, San Diego, CA 92103 USA
[10] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA
[11] Shizuoka Canc Ctr, Shizuoka, Japan
[12] Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan
[13] Univ Ulsan, Coll Med, Seoul, South Korea
[14] Daiichi Sankyo Inc, Basking Ridge, NJ USA
[15] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.9007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9007
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
    Rao, Ding-Yu
    Huang, De-Fa
    Si, Mao-Yan
    Lu, Hua
    Tang, Zhi-Xian
    Zhang, Zu-Xiong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [32] Profile of Reactive Estrogen Species in Women with EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)
    Bodor, J. N.
    Krzizike, D. D.
    Vanderveer, L.
    Eidbo, S.
    Zawislak, C. L.
    Ross, E. A.
    Andrews, A. J.
    Edelman, M. J.
    Treat, J.
    Clapper, M. L.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S75 - S75
  • [33] Leptomeningeal carcinomatosis from EGFR-mutated non-small cell lung cancer
    Iuchi, T.
    Shingyoji, M.
    Setoguchi, T.
    Yoshida, Y.
    Ashinuma, H.
    Hasegawa, Y.
    Sakaida, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] Managing Acquired Resistance in EGFR-Mutated Non-Small Cell Lung Cancer
    Forde, Patrick M.
    Ettinger, David S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (08) : 528 - 532
  • [35] Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
    Alessandro Leonetti
    Sugandhi Sharma
    Roberta Minari
    Paola Perego
    Elisa Giovannetti
    Marcello Tiseo
    British Journal of Cancer, 2019, 121 : 725 - 737
  • [36] Critical points in the management of EGFR-mutated non-small cell lung cancer
    Casaluce, Francesca
    Gridelli, Cesare
    JOURNAL OF THORACIC DISEASE, 2022, 14 (06) : 1748 - 1752
  • [37] Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
    Leonetti, Alessandro
    Sharma, Sugandhi
    Minari, Roberta
    Perego, Paola
    Giovannetti, Elisa
    Tiseo, Marcello
    BRITISH JOURNAL OF CANCER, 2019, 121 (09) : 725 - 737
  • [38] Optimizing adjuvant therapy in EGFR-mutated non-small cell lung cancer
    Shepherd, Annemarie F.
    Preeshagul, Isabel R.
    Shaverdian, Narek
    Wu, Abraham J.
    Gelblum, Daphna Y.
    Gomez, Daniel R.
    Rimner, Andreas
    Simone, Charles B., II
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (23)
  • [39] Depression and Inflammation in Patients with EGFR-Mutated Non-Small Cell Lung Cancer
    Cardona, A.
    Arrieta, O.
    Rojas, L.
    Zatarain-Barron, Z.
    Ricaurte, L.
    Ruiz-Patino, A.
    Martin, C.
    Carranza, H.
    Vargas, C.
    Otero, J.
    Corrales, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S871 - S871
  • [40] NEUROLOGICAL EVOLUTION OF A PATIENT WITH EGFR-MUTATED NON-SMALL CELL LUNG CANCER
    Ianza, A.
    Dicorato, A.
    Guglielmi, A.
    Orlando, V.
    Furlanis, G.
    Curro, F.
    CHEST, 2022, 161 (06) : 333A - 333A
12345